Medipal Holdings

Leading distributor of pharmaceuticals, medical devices, and health-related products with a robust supply chain network. Learn more

Launch date

1898

Employees

2-10 people

Market cap

Enterprise valuation

$2.6b (Public information from Sep 2024)

Tokyo Japan (HQ)

https://www.medipal.co.jp

https://www.linkedin.com/company/medipal-holdings-corporation/

Corporate Venture Fund: Medipal Innovation Fund

Revenues, earnings & profits over time

JPY	2021	2022	2023	2024	2025	2026	2027
Revenues	3.2t	3.3t	3.4t	3.6t	3.6t	3.7t	3.8t
% growth	(1 %)	2 %	2 %	6 %	2 %	2 %	3 %
EBITDA	67.8b	76.4b	79.8b	83.1b	66.8b	68.3b	71.1b
% EBITDA margin	2 %	2 %	2 %	2 %	2 %	2 %	2 %
Profit	23.9b	29.4b	38.8b	41.5b	34.9b	35.6b	38.3b
% profit margin	1 %	1 %	1 %	1 %	1 %	1 %	1 %
EV / revenue	0.1x	0.1x	0.1x	0.1x	0.1x	0.1x	0.1x
EV / EBITDA	3.5x	2.5x	2.3x	3.1x	8.0x	7.8x	7.5x

Date	Investors	Amount	Round
Sep 1995	N/A	N/A	IPO
Jan 2000	N/A	N/A	IPO
Mar 2021	SBI Investment	$92.0m	Post IPO Equity
Total Funding		-

Medipal Holdings Corporation is a prominent player in the distribution of pharmaceuticals, medical devices, and health-related products in Japan. The company serves a diverse range of clients including hospitals, pharmacies, and healthcare institutions. Operating in the healthcare and pharmaceutical market, Medipal leverages an extensive supply chain network to ensure timely and efficient delivery of products. The business model focuses on wholesale distribution, earning revenue through the sale of medical and health-related products. Medipal also invests in logistics and information systems to enhance operational efficiency and customer satisfaction.

Keywords: pharmaceuticals, medical devices, health products, distribution, supply chain, logistics, healthcare, wholesale, Japan, efficiency.